Company Filing History:
2 out of 16 
1 out of 1 
1 out of 197 
Years Active: 1998-2014
Title: The Innovative Contributions of Vaclav Vetvicka
Introduction
Vaclav Vetvicka is a prominent inventor based in Louisville, KY (US), known for his significant contributions to the field of cancer diagnosis and treatment. With a total of five patents to his name, Vetvicka has made strides in developing methods that enhance the understanding and management of cancer.
Latest Patents
Among his latest patents, Vetvicka has developed systems and methods for the diagnosis and prognosis of cancer. These methods involve determining the amount of autoantibodies that are immunoreactive to procathepsin D (pCD) in samples obtained from subjects. Additionally, he has created systems that include an autoantibody immunoreactive pCD antigen, along with a means for detecting the binding of an autoantibody to the antigen. Another notable patent is his chemotherapeutic antineoplastic treatment, which comprises the administration of an effective amount of an antineoplastic agent in conjunction with an effective amount of β-1,3 glucan.
Career Highlights
Throughout his career, Vetvicka has worked with various organizations, including Laboratoires Goemar S.A. and Laboratoire Goemar S.A. His work has focused on advancing medical technologies that aim to improve cancer treatment outcomes.
Collaborations
Vetvicka has collaborated with notable colleagues such as Jean-Claude Yvin and Martin Fusek, contributing to the development of innovative solutions in his field.
Conclusion
Vaclav Vetvicka's work exemplifies the impact of innovation in medical science, particularly in cancer diagnosis and treatment. His patents reflect a commitment to improving patient care through advanced methodologies.